Global Allergy Immunotherapy Market 2017-2021 Featuring ALK-Abello, Allergy Therapeutics, Merck Group and …Business Wire (press release)Global Allergy Immunotherapy Market (2017-2021 Edition), provides an in-depth analysis of the global allergy immun… Continue reading
MD Anderson Team Selected for National Push to Expand ImmunotherapyNewswise (press release)Newswise — A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers at … Continue reading
MD Anderson Team Selected for National Push to Expand ImmunotherapyNewswise (press release)Newswise — A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers at … Continue reading
MD Anderson Team Selected for National Push to Expand ImmunotherapyNewswise (press release)Newswise — A major national effort to expand the reach of cancer immunotherapy to benefit more patients will draw upon the expertise of a team of researchers at … Continue reading
Independent OnlineNew stem cell type expands R&D, regenerative medicine possibilitiesFierceBiotechEmbryonic stem stem cells can develop into many different types of cell and could one day lead to regenerative treatments for various diseases. But th… Continue reading
FDA To Review Experimental Gene Therapy To Treat Childhood BlindnessWBURA panel of experts will advise the Federal and Drug Administration on Thursday on whether to approve Luxturna, a one-time shot that would repair a defective gene that causes inheri… Continue reading
PostObserverSynbiobeta: The Future is NowScienceBlogs (blog)Synthetic biology utilizes high-throughput combinatorial approaches to quickly evolve living systems to make new drugs, foods, and chemicals, to mention a few. It is the culmination of nearly … Continue reading
FierceBiotechAverting toxic side effects from CAR-T cancer treatmentsFierceBiotechTo identify the biomarkers, the research team closely tracked 133 patients participating in a trial of a CAR-T that was developed at Fred Hutch to treat chronic lymphocyt… Continue reading